| Trial ID: | L4997 |
| Source ID: | NCT00687284
|
| Associated Drug: |
Insulin Detemir
|
| Title: |
Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes Mellitus
|
| Acronym: |
START
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin detemir
|
| Outcome Measures: |
Primary: Change in glycaemic control as measured by HbA1c., For the duration of the study | Secondary: Percentage of subjects to reach HbA1c below 7.0% and below or equal 6.5%, After 12 weeks and 24 weeks|The effect on glycaemic control as measured by FPG, After 12 weeks and 24 weeks|Change in body weight, After 12 weeks and 24 weeks|Change in waist and hip perimeter, After 12 weeks and 24 weeks
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
2188
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2008-02
|
| Completion Date: |
2010-06
|
| Results First Posted: |
|
| Last Update Posted: |
2016-10-28
|
| Locations: |
Novo Nordisk Investigational Site, Kosice, 040 01, Slovakia
|
| URL: |
https://clinicaltrials.gov/show/NCT00687284
|
